RAS-mutated patients are less likely to present with upfront obstruction symptoms and advanced stages (stages III and IV) even though the numbers did not reach statistical significance.
← all excerpts
A Study of Molecular Subtypes (Profile) of Colorectal Cancer and Their Correlation with Clinical and Pathological Profile in a Tertiary Care Center in India.
1
—
—